Events for May 2, 2024 – Pharma Journalist

Cell Therapy Potency Assay Summit Leaderboard

Saturday, January 11, 2025
About
Advertise
Subscribe
Contact

Pharma Journalist -

Home
News
Drug Research
Clinical Trials
Manufacturing
Information Technology
Packaging & Labeling
Diseases
Resources
Events
Press Releases

Home
Events

Loading view.

Events Search and Views Navigation

Enter Keyword. Search for Events by Keyword.

Event Views Navigation

List
Month
Day

Select date.

All Day

April 29, 2024 - May 2, 2024

3rd LNP Formulation & Process Development Summit

The Westin Boston Seaport District 425 Summer Street, Boston

Following the success of the first 2 years of the LNP Formulation & Process Development Summit, we are hugely excited to announce the much-anticipated return of this world-leading summit in […]

Previous Day
Next Day

Google Calendar
iCalendar
Outlook 365
Outlook Live
Export .ics file
Export Outlook .ics file

About Us

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia
FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application
Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK
Variant Bio Partners with Novo Nordisk to Discover Metabolic Disease Targets
Tempest Receives Orphan Drug Designation for Amezalpat in HCC Treatment

Industry Reports

AbbVie Completes Acquisition of ImmunoGen

Sanofi to acquire Inhibrx, Inc., adding potential…

Esperion and Daiichi Sankyo Europe Announce $125 Million…

Avistone Biotechnology Announces Closing of Series B…

Apollo Therapeutics Closes $226.5 Million Series C…

5th Genome Editing Therapeutics Summit is only 3 weeks…

Celebrating More than a Decade of Excellence at the World…

Final Week to Save $350: Accelerate Your Gene Editing…

An Interview with Jeffrey Cehelsky, Intellia Therapeutics

Hottest Gene Editing Events Causing Waves in 2024

About
Advertise
Subscribe
Contact

© 2025 - Pharma Journalist. All Rights Reserved.

Pharma Journalist is a product of

Sign in

Welcome, Login to your account.

Forget password? Remember me

Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok Learn More